These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15814631)

  • 1. Minimal residual disease in acute myeloid leukemia is predicted by an apoptosis-resistant protein profile at diagnosis.
    van Stijn A; Feller N; Kok A; van der Pol MA; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Apr; 11(7):2540-6. PubMed ID: 15814631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
    van Stijn A; Kok A; van der Pol MA; Feller N; Roemen GM; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2003 Apr; 17(4):780-6. PubMed ID: 12682637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of Bcl-XL gene expression for remission induction is influenced by cytogenetics in adult acute myeloid leukemia.
    Schaich M; Illmer T; Seitz G; Mohr B; Schäkel U; Beck JF; Ehninger G
    Haematologica; 2001 May; 86(5):470-7. PubMed ID: 11410409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival.
    van Rhenen A; Feller N; Kelder A; Westra AH; Rombouts E; Zweegman S; van der Pol MA; Waisfisz Q; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Sep; 11(18):6520-7. PubMed ID: 16166428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia.
    van Stijn A; van der Pol MA; Kok A; Bontje PM; Roemen GM; Beelen RH; Ossenkoppele GJ; Schuurhuis GJ
    Haematologica; 2003 May; 88(5):497-508. PubMed ID: 12745269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma.
    Soini Y; Kinnula V; Kaarteenaho-Wiik R; Kurttila E; Linnainmaa K; Pääkkö P
    Clin Cancer Res; 1999 Nov; 5(11):3508-15. PubMed ID: 10589765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
    van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
    Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
    Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
    Salakou S; Kardamakis D; Tsamandas AC; Zolota V; Apostolakis E; Tzelepi V; Papathanasopoulos P; Bonikos DS; Papapetropoulos T; Petsas T; Dougenis D
    In Vivo; 2007; 21(1):123-32. PubMed ID: 17354625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma.
    de Vicente JC; Olay S; Lequerica-Fernandez P; Sánchez-Mayoral J; Junquera LM; Fresno MF
    J Oral Pathol Med; 2006 Mar; 35(3):140-5. PubMed ID: 16454809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T; Babusíková O
    Neoplasma; 2006; 53(6):500-6. PubMed ID: 17167719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of minimal residual disease in patients with acute myeloid leukemia].
    Gal'tseva IV; Savchenko VG; Kulikov SM; Parovichnikova EN; Miterev GIu; Maslova ER; Isaev VG
    Ter Arkh; 2003; 75(7):8-14. PubMed ID: 12934474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma.
    Zhang M; Zhang P; Zhang C; Sun J; Wang L; Li J; Tian Z; Chen W
    J Oral Pathol Med; 2009 Mar; 38(3):307-13. PubMed ID: 18710422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.
    Maurillo L; Buccisano F; Del Principe MI; Del Poeta G; Spagnoli A; Panetta P; Ammatuna E; Neri B; Ottaviani L; Sarlo C; Venditti D; Quaresima M; Cerretti R; Rizzo M; de Fabritiis P; Lo Coco F; Arcese W; Amadori S; Venditti A
    J Clin Oncol; 2008 Oct; 26(30):4944-51. PubMed ID: 18606980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multidrug resistance markers monitoring in acute myeloid leukemia cells].
    Jankovicová K; Krejsek J; Kopecký O; Voglová J; Novosad J
    Cas Lek Cesk; 2004; 143(7):471-5. PubMed ID: 15373290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of vascular endothelial growth factor on apoptosis and expression of Bcl-2 and Mcl-1 in acute leukemia cells].
    Liao XL; Xie XT; Li BS; Li L; Yang LL
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):491-5. PubMed ID: 17178043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden.
    Feller N; Jansen-van der Weide MC; van der Pol MA; Westra GA; Ossenkoppele GJ; Schuurhuis GJ
    Exp Hematol; 2005 Jan; 33(1):120-30. PubMed ID: 15661405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis induced by DNA primase inhibitor 3,3'-diethyl-9-methylthia-carbocyanine iodide in human leukemia HL-60 cells.
    Li ZM; Jiang WQ; Guan ZZ; Zhu XF; Zhou JM; Xie BF; Feng GK; Zhu ZY; Liu ZC
    Yao Xue Xue Bao; 2006 Oct; 41(10):978-84. PubMed ID: 17184117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of apoptosis in stage IB squamous cervical carcinoma.
    Van de Putte G; Holm R; Lie AK; Baekelandt M; Kristensen GB
    J Clin Pathol; 2005 Jun; 58(6):590-4. PubMed ID: 15917408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.